retatrutide glp-1 gip glucagon agonist Retatrutide, a GIP, and receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide 10mg — Triple Receptor
Pay in 4 interest-free payments of $5.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30





:format(jpg)/d2lnr5mha7bycj.cloudfront.net/product-image/file/large_82b0fc1a-4cca-47cb-8a1b-35028670df5c.jpg)



















